Default object view. Click to create a custom template, Node ID: 112136, Object ID: 67006

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled...

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

No relation

Yes

No relation

No

30/05/2015 2:03 pm

No